Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuang Lu

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Regulatory Toxicology and Pharmacology : RTP|November 18, 2019
Qualification of impurities based on metabolite dataLars Weidolf, Thomas Andersson, Joel P Bercu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 22, 2018
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical CenterYung-Ting Cheng, Chih-Hung Chiang, Yeong-Shiau Pu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 11, 2009
The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of AmericaScott W Grimm, Heidi J Einolf, Steven D Hall, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 8, 2016
Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions-an Industry PerspectiveTonika Bohnert, Aarti Patel, Ian Templeton, et al.
Journal of Medicinal Chemistry|April 28, 2006
Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8)Shomir Ghosh, Amy Elder, Jianping Guo, et al.
ACS Medicinal Chemistry Letters|November 19, 2025
Discovery of Kinesin KIF18A Inhibitor ATX020: Tactical Application of Silicon Atom ReplacementBrian A Sparling, Hyelee Lee, Mary-Margaret Zablocki, et al.
Journal of Medicinal Chemistry|April 29, 2025
Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9Matthew H Daniels, Jennifer Castro, Young-Tae Lee, et al.
Cancer Research|November 26, 2024
A Potent, Selective, Small-Molecule Inhibitor of DHX9 Abrogates Proliferation of Microsatellite Instable Cancers with Deficient Mismatch RepairJennifer Castro, Matthew H Daniels, David Brennan, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Regulatory Toxicology and Pharmacology : RTP|November 18, 2019
Qualification of impurities based on metabolite dataLars Weidolf, Thomas Andersson, Joel P Bercu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 22, 2018
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical CenterYung-Ting Cheng, Chih-Hung Chiang, Yeong-Shiau Pu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 11, 2009
The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of AmericaScott W Grimm, Heidi J Einolf, Steven D Hall, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 8, 2016
Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions-an Industry PerspectiveTonika Bohnert, Aarti Patel, Ian Templeton, et al.
Journal of Medicinal Chemistry|April 28, 2006
Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8)Shomir Ghosh, Amy Elder, Jianping Guo, et al.
ACS Medicinal Chemistry Letters|November 19, 2025
Discovery of Kinesin KIF18A Inhibitor ATX020: Tactical Application of Silicon Atom ReplacementBrian A Sparling, Hyelee Lee, Mary-Margaret Zablocki, et al.
Journal of Medicinal Chemistry|April 29, 2025
Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9Matthew H Daniels, Jennifer Castro, Young-Tae Lee, et al.
Cancer Research|November 26, 2024
A Potent, Selective, Small-Molecule Inhibitor of DHX9 Abrogates Proliferation of Microsatellite Instable Cancers with Deficient Mismatch RepairJennifer Castro, Matthew H Daniels, David Brennan, et al.
Pageof 8